Levodopa (physiology) < Levodopa (therapeutic use) < Levodopa (toxicity)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 205.
[20-40] [0 - 20][0 - 50][40-60]

Ident.	Authors (with country if any)	Title
000224 (2002)	Luc J P. Defebvre [France] ; Pierre Krystkowiak ; Jean-Louis Blatt ; Alain Duhamel ; Jean-Louis Bourriez ; Myriame Périna ; Serge Blond ; Jean-Daniel Guieu ; Alain Destée [France]	Influence of pallidal stimulation and levodopa on gait and preparatory postural adjustments in Parkinson's disease.
000239 (2002)	Paul Krack [France] ; Valérie Fraix ; Alexandre Mendes ; Alim-Louis Benabid ; Pierre Pollak	Postoperative management of subthalamic nucleus stimulation for Parkinson's disease.
000242 (2002)	M. Bailbé ; S. Karolewicz ; J Ph Neau ; P. Dumas ; R. Gil	[Hallucinations, delusions, and nocturnal events in 152 Parkinson's patients: a regional survey].
000245 (2001)	J. Xie [France] ; P. Krack ; A L Benabid ; P. Pollak	Effect of bilateral subthalamic nucleus stimulation on parkinsonian gait.
000248 (2002)	I. Ghorayeb ; F. Yekhlef ; V. Chrysostome ; E. Balestre ; B. Bioulac ; F. Tison	Sleep disorders and their determinants in multiple system atrophy
000255 (2002)	D. Devos [France] ; Ph Derambure ; J L Bourriez ; D F Cassim ; S. Blond ; J D Guieu ; A. Destée ; L. Defebvre	Influence of internal globus pallidus stimulation on motor cortex activation pattern in Parkinson's disease.
000259 (2002)	André Nieoullon [France]	Dopamine and the regulation of cognition and attention.
000268 (2002)	Anne-Marie Bonnet [France]	[Alpha-2 adrenergic receptors and Parkinson's disease].
000270 (2002)		Selegiline: a second look. Six years later: too risky in Parkinson's disease.
000279 (2002)	P D Charles [France] ; N. Van Blercom ; P. Krack ; S L Lee ; J. Xie ; G. Besson ; A-L Benabid ; P. Pollak	Predictors of effective bilateral subthalamic nucleus stimulation for PD.
000286 (2002)	V. Czernecki [France] ; B. Pillon ; J L Houeto ; J B Pochon ; R. Levy ; B. Dubois	Motivation, reward, and Parkinson's disease: influence of dopatherapy.
000297 (2002)	Y. Tsuboi [États-Unis] ; M. Baker ; M L Hutton ; R J Uitti ; O. Rascol ; M-B Delisle ; X. Soulages ; J R Murrell ; B. Ghetti ; M. Yasuda ; O. Komure ; S. Kuno ; K. Arima ; N. Sunohara ; T. Kobayashi ; Y. Mizuno ; Z K Wszolek	Clinical and genetic studies of families with the tau N279K mutation (FTDP-17).
000308 (2003)	Serge Pinto [France] ; Michèle Gentil ; Valérie Fraix ; Alim-Louis Benabid ; Pierre Pollak	Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease.
000313 (2003)	Kathy Dujardin [France] ; Luc Defebvre [France] ; Pierre Krystkowiak ; Jean François Degreef ; Alain Destée [France]	Executive function differences in multiple system atrophy and Parkinson's disease.
000315 (2003)	G. Fénelon [France] ; S. Giménez-Roldán ; J L Montastruc ; F. Bermejo ; F. Durif ; I. Bourdeix ; J-J Péré ; L. Galiano ; J. Schadrack	Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study.
000326 (2003)	Aurélie Funkiewiez [France] ; Claire Ardouin ; Paul Krack ; Valérie Fraix ; Nadège Van Blercom ; Jing Xie ; Elena Moro ; Alim-Louis Benabid ; Pierre Pollak	Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
000330 (2003)	Erwan Bézard [France] ; Sandrine Ferry ; Ulrich Mach ; Holger Stark ; Ludovic Leriche ; Thomas Boraud ; Christian Gross ; Pierre Sokoloff	Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.
000347 (2003)	Olivier Rascol [France]	Monoamine oxidase inhibitors--is it time to up the TEMPO?
000356 (2003)	Ebba Lohmann [France] ; Magali Periquet ; Vincenzo Bonifati ; Nick W. Wood ; Giuseppe De Michele ; Anne-Marie Bonnet ; Valérie Fraix ; Emmanuel Broussolle ; Martin W I M. Horstink ; Marie Vidailhet ; Patrice Verpillat ; Thomas Gasser ; David Nicholl ; Hélio Teive ; Salmo Raskin ; Olivier Rascol ; Alain Destée [France] ; Merle Ruberg ; Francesca Gasparini ; Giuseppe Meco ; Yves Agid [France] ; Alexandra Durr ; Alexis Brice	How much phenotypic variation can be attributed to parkin genotype?
000359 (2003)	Julie Hudry [France] ; Stéphane Thobois ; Emmanuel Broussolle ; Patrice Adeleine ; Jean-Pierre Royet	Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson's disease.
000363 (2003)	D. Devos [France] ; M. Kroumova ; R. Bordet ; H. Vodougnon ; J D Guieu ; C. Libersa ; A. Destee	Heart rate variability and Parkinson's disease severity.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Levodopa (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Levodopa (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Levodopa (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024